Alexandra Nathalie Kopic

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Baxalta Gmbh, Takeda Pharmaceutical Company Limited. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandra Nathalie Kopic. Retrieved from https://idiyas.com/inventor/alexandra-nathalie-kopic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 1

Company Filing History:

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11779635 - Subcutaneous administration of ADAMTS13 (2023-10-10),

2. 11185575 - Subcutaneous administration of ADAMTS13 (2021-11-30),

3. 10413600 - Subcutaneous administration of ADAMTS13 (2019-09-17),

4. 9611467 - Subcutaneous administration of ADAMTS13 (2017-04-04),

Title: The Innovative Contributions of Alexandra Nathalie Kopic

Introduction

Alexandra Nathalie Kopic is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical science, particularly in the area of ADAMTS13 formulations. With a total of four patents to her name, Kopic's work has the potential to impact the treatment of diseases associated with blood disorders.

Latest Patents

One of Kopic's latest patents focuses on the subcutaneous administration of ADAMTS13. This invention relates to methods of administering ADAMTS13 formulations to treat diseases or conditions associated with ADAMTS13 and von Willebrand factor (VWF) dysfunction. The patent provides evidence of the unexpectedly high bioavailability of ADAMTS13 formulations when administered subcutaneously, showcasing her innovative approach to medical treatment.

Career Highlights

Throughout her career, Kopic has worked with notable companies in the pharmaceutical industry, including Baxalta GmbH and Takeda Pharmaceutical Company Limited. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in medical therapies.

Collaborations

Kopic has collaborated with esteemed colleagues such as Barbara Plaimauer and Hanspeter Rottensteiner. These partnerships have further enriched her research and development efforts, leading to innovative solutions in her field.

Conclusion

Alexandra Nathalie Kopic's contributions to the field of medical science through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of blood disorders, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.